CXCL1 and cancer: The study thus revealed the upregulation of several genes that are involved in the acute phase and cancer development process, and which could serve as potential HCC markers, such as SAA, which is an early stage marker for acute (and chronic) inflammatory disease and CXCL1 is a prognostic indicator for poor outcome.